human
rhinovirus
hrv
virus
predominantli
associ
common
cold
highli
preval
immunocompet
immunocompromis
individu
prior
develop
sensit
molecular
viral
detect
assay
influenza
respiratori
syncyti
viru
parainfluenza
viru
common
concern
respiratori
viral
pathogen
detect
hematopoiet
cell
transplant
hct
recipi
due
develop
polymeras
chain
reaction
pcr
assay
viral
detect
hrv
known
common
virus
detect
respiratori
specimen
hct
recipi
account
case
viral
respiratori
infect
patient
figur
due
high
preval
abil
caus
progress
infect
hrv
also
signific
caus
lower
respiratori
tract
infect
lrti
hct
recipi
tabl
hrv
infect
also
common
solid
organ
transplant
sot
recipi
although
incid
known
among
sot
recipi
whole
lung
transplant
recipi
data
older
retrospect
prospect
studi
suggest
incid
among
patient
posit
respiratori
sampl
figur
recent
prospect
surveil
studi
lung
transplant
recipi
hrv
repres
posit
sampl
among
symptomat
lung
transplant
recipi
hrv
repres
respiratori
virus
detect
hrv
member
picornavirida
famili
classifi
three
speci
hrva
hrvb
hrvc
base
similar
genom
organ
capsid
featur
conserv
sequenc
total
number
genotyp
continu
grow
new
genotyp
character
current
least
uniqu
genotyp
describ
due
poor
growth
tradit
viral
cultur
model
hrvc
recogn
develop
molecular
diagnost
techniqu
thu
hrvc
novel
speci
rather
one
circul
unnot
due
lack
appropri
diagnost
assay
sever
biolog
characterist
hrvc
differenti
speci
hrva
hrvb
hrva
hrvb
use
ldlr
cell
attach
entri
wherea
appear
hrvc
may
util
distinct
receptor
cadherinrel
famili
member
associ
asthma
suscept
addit
hrvc
speci
stabl
higher
temperatur
readili
infect
upper
lower
airway
wherea
hrva
hrvb
speci
tend
limit
sinus
upper
airway
biolog
characterist
thought
play
role
variat
clinic
outcom
observ
among
differ
speci
immunocompet
patient
hrv
present
afebril
selflimit
syndrom
character
rhinorrhea
nasal
congest
malais
less
frequent
sore
throat
mild
cough
hoars
hrv
may
also
associ
exacerb
sinus
chronic
bronchiti
asthma
lower
respiratori
tract
syndrom
atyp
pneumonia
otherwis
healthi
peopl
includ
young
elderli
specif
mechan
hrv
produc
lung
diseas
well
understood
hrv
also
implic
asthma
chronic
obstruct
pulmonari
diseas
copd
exacerb
mechan
poorli
defin
widespread
avail
pcr
diagnost
data
emerg
incid
clinic
relev
hrv
infect
immunocompromis
patient
earli
studi
reli
cultur
detect
hrv
specif
insensit
method
standard
viral
cultur
system
optim
hrv
detect
especi
hrvc
exampl
fred
hutchinson
cancer
center
surveil
studi
detect
hrv
specimen
one
lower
respiratori
tract
specimen
prospect
studi
md
anderson
cancer
center
cultur
specimen
specif
hrv
lower
temperatur
roller
cultur
method
report
hrv
infect
associ
substanti
morbid
mortal
myelosuppress
patient
studi
approxim
one
third
adult
hct
recipi
develop
symptomat
hrv
infect
prior
engraft
progress
upper
respiratori
tract
symptom
lrti
case
pneumonia
fatal
lung
biopsi
autopsi
reveal
find
consist
interstiti
pneumon
andor
ard
situ
evalu
perform
definit
assess
hrv
infect
similar
report
evid
lrti
base
radiograph
bal
find
continu
note
remain
unknown
pneumonia
direct
caus
viral
invas
lung
tissu
host
respons
lung
evid
vitro
vivo
replic
lower
respiratori
tract
shown
experiment
infect
hrv
isol
human
volunt
intranas
hrv
challeng
situ
hybrid
use
rtpcr
continu
provid
new
inform
frequenc
hrv
infect
studi
bal
sampl
hct
recipi
test
use
rtpcr
hrv
detect
six
patient
mortal
rate
high
two
six
patient
show
persist
hrv
infect
howev
hrvinfect
patient
signific
coinfect
certain
whether
hrv
infect
direct
caus
poor
prognosi
small
cohort
patient
hematolog
malign
lrti
associ
hypoalbuminemia
bacteri
copathogen
seen
patient
recent
studi
shown
immunocompromis
adult
hrv
demonstr
similar
hospit
admiss
rate
intens
care
unit
admiss
mortal
rate
patient
pandem
influenza
sever
report
link
hrv
infect
sever
respiratori
failur
even
death
furthermor
recent
present
data
suggest
lrti
associ
hrv
lead
mortal
rate
compar
rsv
influenza
viru
piv
independ
presenc
copathogen
risk
factor
mortal
follow
hrv
lrti
includ
bone
marrow
stem
cell
sourc
oxygen
requir
time
diagnosi
steroid
use
mgkg
prior
diagnosi
factor
may
influenc
clinic
sever
includ
presenc
hrv
rna
blood
viral
load
hrv
speci
type
howev
data
exist
immunocompromis
patient
date
hrv
viral
rna
detect
sera
pediatr
patient
sever
hrv
respiratori
infect
hrvc
predomin
speci
healthi
pediatr
patient
increas
respiratori
viral
load
associ
hrv
lrti
hrvc
implic
virul
pathogen
other
howev
shown
lack
correl
hrvc
oxygen
requir
length
hospit
coinfect
predomin
hrvc
hct
recipi
also
describ
small
studi
higher
rate
pneumonia
patient
hrvc
detect
upper
respiratori
tract
small
cohort
patient
hematolog
malign
rate
lrti
differ
patient
infect
hrva
hrvb
hrvc
rel
risk
hrvc
infect
immunocompromis
popul
remain
unknown
research
need
defin
role
strain
differ
outcom
detect
diagnosi
respiratori
viral
infect
prior
transplant
common
clinic
concern
recent
evalu
small
cohort
certain
virus
larg
prospect
surveil
cohort
allogen
hct
recipi
detect
hrv
pretranspl
associ
significantli
fewer
day
aliv
hospit
significantli
higher
mortal
day
posttranspl
larger
prospect
studi
need
determin
risk
factor
posttranspl
complic
role
viral
load
symptom
burden
time
transplant
need
potenti
delay
transplant
patient
hrv
present
prior
transplant
ultim
issu
viral
causal
diseas
evalu
prophylact
treatment
modal
need
address
impact
hrv
infect
prior
sot
known
like
hct
recipi
sot
recipi
expos
highli
immunosuppress
regimen
leav
suscept
respiratori
viral
infect
lung
transplant
recipi
ad
disadvantag
alter
lung
immun
due
factor
impair
ciliari
clearanc
poor
cough
reflex
abnorm
lymphat
drainag
factor
predispos
lower
respiratori
tract
infect
impact
hrv
outcom
lung
transplant
recipi
rang
asymptomat
infect
sever
diseas
pool
analysi
respiratori
virus
detect
lung
transplant
recipi
virus
detect
five
time
frequent
respiratori
symptom
present
correl
higher
symptom
score
higher
rhinoviru
load
upper
respiratori
tract
demonstr
although
even
asymptomat
patient
rel
high
viral
load
rel
rate
progress
upper
lower
tract
diseas
hrv
specif
known
although
effect
lung
function
evalu
aggreg
respiratori
virus
suggest
declin
forc
expiratori
volum
hrv
specif
loss
similar
seen
respiratori
virus
correl
respiratori
viral
infect
acut
reject
chronic
reject
bronchiol
obliteran
syndrom
bo
remain
somewhat
unclear
sever
conflict
find
respiratori
virus
evalu
aggreg
recent
larg
cohort
lung
transplant
recipi
howev
show
independ
associ
respiratori
viral
infect
hrv
chronic
lung
allograft
dysfunct
multivari
model
associ
influenc
time
effect
within
shorter
period
follow
respiratori
infect
larger
prospect
studi
invest
individu
virus
need
clearli
assess
impact
outcom
unlik
paramyxovirus
hrv
infectioncannot
diagnos
base
characterist
histopatholog
chang
chang
cell
morpholog
past
cell
cultur
use
diagnos
hrv
infect
use
multipl
cell
line
low
temperatur
often
roll
tube
cell
line
util
detect
hrv
may
detect
enterovirus
hrv
isol
distinguish
enterovirus
labil
acid
loss
viral
titer
follow
exposur
ph
commerci
avail
antigendetect
assay
simpl
kit
detect
hrv
rtpcr
dramat
improv
abil
detect
character
hrv
current
assay
least
two
three
time
sensit
convent
cultur
method
pcr
assay
abl
distinguish
enterovirus
hrv
instead
acid
labil
assay
type
hrv
base
pcr
amplif
sequenc
variat
region
also
describ
new
standard
method
detect
strain
hrv
describ
howev
commerci
avail
multiplex
respiratori
viral
pcr
panel
contain
primerprob
set
crossreact
enteroviru
hrv
strain
new
strain
type
hrv
detect
frequent
diseas
associ
hrv
describ
use
new
divers
molecular
method
approv
antivir
treatment
hrv
infect
sever
agent
evalu
preclin
clinic
trial
treatment
hrv
infect
immunocompet
host
includ
capsid
bind
inhibitor
proteas
inhibitor
rna
synthesi
inhibitor
none
agent
evalu
immunocompromis
host
given
high
preval
potenti
sever
hrv
infect
popul
great
need
drug
develop
clinic
trial
prevent
treatment
lrti
outsid
transplant
recipi
potenti
need
intervent
popul
patient
asthma
copd
prevent
diseas
exacerb
cov
frequent
caus
common
cold
littl
known
role
cov
immunocompromis
patient
tabl
human
group
subtyp
human
group
cov
origin
report
caus
human
respiratori
ill
avail
sophist
diagnost
tool
rtpcr
facilit
detect
cov
normal
immunocompromis
person
improv
molecular
method
viral
discoveri
facilit
recent
identif
novel
group
human
cov
accur
clinic
epidemiolog
cov
infect
begin
emerg
known
four
known
subtyp
cov
circul
simultan
addit
common
cold
cov
associ
upper
respiratori
tract
infect
lrti
person
without
underli
condit
lung
transplant
recipi
cov
appear
second
common
respiratori
virus
picornavirus
detect
rate
posit
sampl
figur
prospect
surveil
cohort
lung
transplant
recipi
coronavirus
detect
posit
sampl
second
picornavirus
two
addit
cov
associ
outbreak
sever
acut
respiratori
syndromeassoci
cov
sarscov
recent
describ
middl
east
respiratori
syndromecov
merscov
thesar
outbreak
origin
guangdong
provinc
china
character
lifethreaten
atyp
pneumonia
spread
close
contact
infect
human
mostli
household
contact
health
care
worker
sarscov
current
circul
world
recent
human
case
infect
report
china
mer
covfirst
emerg
arabian
peninsula
sinc
travelassoci
case
found
number
countri
outsid
region
adult
fatal
rate
estim
children
asymptomat
infect
common
patient
underli
medic
condit
increas
risk
littl
data
incid
ofsarscov
andmerscov
immunocompromis
host
although
immun
suppress
consid
risk
factor
sarscov
describ
liver
transplant
recipi
patient
myelodysplast
syndrom
merscov
describ
patient
chronic
immunosuppress
renal
transplant
recipi
broad
rang
clinic
present
cov
report
caus
pneumonia
children
immunocompromis
patient
treat
hematolog
malign
role
coronaviru
viru
infect
prior
transplant
known
although
cov
infect
result
rel
mild
upper
respiratori
tract
infect
virus
associ
sever
lrti
eg
bronchiol
pneumonia
patient
immunosuppress
asthma
prematur
one
retrospect
studi
carri
year
cov
detect
six
immunocompromis
acut
lymphocyt
leukemia
one
renal
transplant
recipi
five
patient
febril
time
coronaviru
present
fever
last
day
patient
initi
present
rhinorrhea
nasal
discharg
two
children
cough
present
symptom
chest
radiograph
one
three
children
abnorm
lrti
base
decreas
oxygen
satur
tachypnea
abnorm
chest
radiograph
present
one
child
leukemia
significantli
neutropen
lymphopen
time
cov
detect
cov
associ
lrti
hct
recipi
sometim
fatal
outcom
clinic
characterist
sarscov
merscov
infect
hct
sot
patient
well
describ
present
rang
mild
symptom
respiratori
failur
death
advent
rtpcr
techniqu
detect
cov
limit
reliabl
identif
cov
problemat
earli
detect
techniqu
isol
two
origin
use
organ
cultur
human
embryon
trachea
morpholog
determin
use
neg
stain
electron
microscopi
advent
molecular
detect
method
increas
interest
cov
detect
sar
outbreak
new
strain
cov
discov
new
rtpcr
assay
develop
facilit
studi
virus
base
rtpcr
assay
four
strain
nonsar
cov
appear
cocircul
nonsumm
month
temper
climat
associ
symptomat
diseas
immunocompromis
host
guidanc
rtpcr
serolog
assay
confirm
merscov
found
world
health
organ
websit
approv
antivir
prophylaxi
treatment
cov
infect
support
care
remain
paramount
manag
patient
infect
coronavirus
though
sever
antivir
use
sarscov
epidem
clear
benefit
could
establish
systemat
review
oral
ribavirin
evalu
retrospect
studi
treatment
merscov
immunocompet
individu
decreas
surviv
note
one
studi
compar
match
control
howev
larger
prospect
studi
need
show
true
efficaci
shed
coronavirus
may
persist
month
routin
infect
control
practic
encourag
ev
part
picornavirida
famili
virus
associ
sever
ill
immunocompromis
host
ev
includ
poliovirus
coxsackievirus
echovirus
classifi
four
speci
enteroviru
eva
evb
evc
evd
risk
infect
subsequ
poor
outcom
appear
heavili
influenc
age
although
factor
sex
socioeconom
statu
play
role
gener
popul
ev
activ
either
sporad
epidem
sever
outbreak
describ
ev
typic
found
summer
earli
autumn
temper
climat
first
identifi
california
sinc
associ
sever
small
outbreak
us
intern
summer
sever
hundr
case
sever
respiratori
ill
children
unit
state
found
associ
infect
sever
addit
cluster
describ
worldwid
ev
caus
wide
spectrum
ill
immunocompet
individu
includ
asymptomat
infect
poliomyel
mening
enceph
cardiac
diseas
muscl
diseas
eye
infect
respiratori
infect
exanthem
neonat
diseas
frequent
describ
manifest
immunocompromis
patient
respiratori
diseas
although
incid
spectrum
diseas
known
accord
one
studi
ev
associ
lower
respiratori
tract
infect
mortal
howev
larger
studi
need
establish
specif
risk
factor
wors
outcom
confirm
case
infect
children
occur
primarili
patient
underli
lung
diseas
asthma
histori
wheez
also
associ
sever
case
acut
flaccid
paralysi
children
outbreak
unit
state
although
definit
causat
yet
establish
impact
infect
immunocompromis
host
known
howev
associ
sever
ill
describ
eight
adult
immunocompromis
patient
presumpt
infect
includ
hct
recipi
addit
one
recent
report
adult
confirm
infect
includ
solid
organ
transplant
recipi
depend
clinic
scenario
ev
detect
number
clinic
specimen
includ
cerebr
spinal
fluid
serum
respiratori
specimen
cardiac
tissu
stool
ev
may
identifi
throat
sampl
well
fecal
specimen
cerebrospin
fluid
commerci
multiplex
pcr
assay
contain
primerprob
set
may
cross
react
rhinovirus
enterovirus
specif
rtpcr
develop
cdc
made
public
avail
approv
antivir
approv
treatment
ev
intraven
immunoglobulin
ivig
use
treatment
neonat
enterovir
sepsi
effect
clinic
outcom
highli
depend
presenc
specif
neutral
antibodi
time
administr
pleconaril
oral
capsid
inhibitor
activ
picornavirus
evalu
treatment
enterovir
infect
includ
mening
neonat
sepsi
respiratori
infect
avail
treatment
capsid
binder
proteas
inhibitor
polymeras
inhibitor
variou
stage
develop
none
current
avail
treatment
enterovir
infect
studi
shown
efficaci
immunocompromis
host
human
bocaviru
hbov
newli
identifi
human
parvoviru
origin
identifi
random
pcr
amplificationclon
techniqu
pool
respiratori
secret
hospit
children
respiratori
tract
symptom
viru
name
human
bocaviru
due
related
genom
organ
two
parvovirus
bovin
parvoviru
minut
viru
canin
famili
parvovirida
viru
continu
detect
young
children
winter
season
relationship
hbov
respiratori
diseas
immunocompromis
patient
yet
clear
preliminari
evid
date
demonstr
case
report
dissemin
hbov
infect
involv
respiratori
tract
blood
stool
sever
patient
sometim
associ
gvhd
prolong
viral
shed
fece
studi
report
littl
evid
link
viru
pulmonari
patholog
sever
respiratori
diseas
hct
lung
transplant
recipi
research
necessari
link
viru
diseas
transplant
recipi
specif
antivir
therapi
avail
respiratori
virus
signific
concern
follow
hct
sot
associ
substanti
morbid
mortal
even
among
virus
tradit
concern
pathogen
new
sensit
diagnost
assay
allow
routin
detect
rhinovirus
enterovirus
coronavirus
bocaviru
addit
data
epidemiolog
risk
factor
outcom
infect
impact
differ
viral
strain
desper
need
preliminari
studi
suggest
detect
virus
prior
transplant
may
affect
outcom
addit
studi
need
explor
import
clinic
area
furthermor
new
antivir
develop
import
identifi
highrisk
patient
may
benefit
treatment
final
better
understand
virus
abl
inform
better
infect
prevent
strategi
remain
mainstay
viral
control
